Acute stent thrombosis after primary percutaneous coronary intervention insights from the EUROMAX Trial (European Ambulance Acute Coronary Syndrome Angiography)

JACC: Cardiovascular Interventions

Volumn 8, Issue 1, 2015, Pages 214-220

  Clemmensen, Peter ^a   Wiberg, Sebastian ^b   Van'T Hof, Arnoud ^c   Deliargyris, Efthymios N ^d   Pierre Coste, M ^e   Ten Berg, Jurrien ^f   Cavallini, Claudio ^g   Hamon, Martial ^h   Dudek, Dariusz ⁱ   Zeymer, Uwe ^j   Tabone, Xavier ^k   Kristensen, Steen D ^l   Bernstein, Debra ^d   Anthopoulos, Prodromos ^d   Prats, Jayne ^d   Steg, Philippe Gabriel ^m,n,o,p  

^a NYKØBING FALSTER HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ISALA HOSPITAL   (Netherlands)

^d MEDICINES COMPANY   (United States)

^e HAUT LÉVÊQUE HOSPITAL   (France)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^h UNIVERSITÉ DE CAEN   (France)

ⁱ UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^j KLINIKUM LUDWIGSHAFEN   (Germany)

^k CH de Bourges   (France)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m UNIVERSITÉ PARIS DESCARTES   (France)

ⁿ BICHAT HOSPITAL   (France)

^o Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^p NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

more..

Author keywords

Bivalirudin; Percutaneous coronary intervention; ST segment elevation myocardial infarction; Stent thrombosis

Indexed keywords

CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PRASUGREL; TICAGRELOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MALE; MAXIMUM LIKELIHOOD METHOD; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STUDY DESIGN; ADVERSE EFFECTS; AMBULANCE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CORONARY THROMBOSIS; DEVICES; DRUG ADMINISTRATION; EUROPE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL MODEL; STENT; TIME; TREATMENT OUTCOME;

AGED; AMBULANCES; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HEPARIN; HIRUDINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84921374025     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.11.002     Document Type: Article

References (22)

1. Dangas GD, Caixeta A, Mehran R, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 2011;123:1745-56.
2. Kukreja N, Onuma Y, Garcia-Garcia HM, et al., for the Interventional Cardiologists of the Thoraxcenter (2000 to 2005). The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. J Am Coll Cardiol Intv 2009;2:534-41.
3. Luscher TF, Steffel J, Eberli FR, et al. Drugeluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-8.
4. Nakano M, Yahagi K, Otsuka F, et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coll Cardiol 2014;63:2510-20.
5. Dangas GD, Claessen BE, Mehran R, et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. J Am Coll Cardiol Intv 2012;5:1097-105.
6. Stone GW, Witzenbichler B, Guagliumi G, et al., for the HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30.
7. Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 2011;377:2193-204.
8. Steg PG, van't Hof A, Hamm CW, et al., for the EUROMAX Investigators. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 2013;369:2207-17.
9. Hirschl MM, Mayr H, Erhart F, et al. Prehospital treatment of patients with acute myocardial infarction with bivalirudin. Am J Emerg Med 2012;30:12-7.
10. Mehta SR, Jolly SS, Cairns J, et al., for the RIVAL Investigators. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol 2012;60:2490-9.
11. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011;32:1854-64.
12. Hamon M, Pristipino C, Di Mario C, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology. Euro-Intervention 2013;8:1242-51.
13. Steg PG, James SK, Atar D, et al., for the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
14. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:485-510.
15. Shahzad A, Cooper RM, Stables RH. Antithrombotic therapy in PCI: why not heparin? Euro-Intervention 2013;9:423-6.
16. Steg PG, James S, Harrington RA, et al., for the PLATO Study Group. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 2010;122:2131-41.
17. Montalescot G, Wiviott SD, Braunwald E, et al., for the TRITON-TIMI 38 Investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for STelevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
18. Steg PG, van't Hof A, Clemmensen P, et al. Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized openlabel ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention. Am Heart J 2013;166:960-7.
19. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
20. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
21. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991;115:256-65.
22. Alexopoulos D, Xanthopoulou I, Gkizas V, et al. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2012;5:797-804.